Question 14061
Topic: Biology, Genetics & Bone HealingA patient with metastatic breast cancer to the bone is treated with denosumab. Which of the following best describes the molecular target of this monoclonal antibody?
Correct Answer & Explanation
. Receptor activator of nuclear factor kappa-B ligand (RANKL)